Skip to main content
Back to OrbiMed

OrbiMed's Life Science Portfolio

Browse 30 Life Science companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Life Science Companies
30
Total Funding in Life Science
$4.6B

Life Science Portfolio Companies (30)

Export
BiotechnologyHealth CareLife ScienceOncology

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.

San Diego, United States
August 2021
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.

Seattle, United States
August 2021
$157.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncologyPrecision Medicine

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

Boston, United States
July 2024
$150.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

Erasca is a developer of oncology drugs intended to provide precision oncology options.

San Diego, United States
July 2026
$632.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Berkeley, United States
July 2025
$54.5M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

MiroBio is Harnessing the natural control mechanisms of the immune system.

Oxford, United Kingdom
June 2022
$97.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscienceTherapeutics

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Cambridge, United States
June 2024
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Boulder, United States
June 2026
$460.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife Science

Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.

Austin, United States
June 2026
$75.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

San Francisco, United States
May 2026
$1.3B
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceOncology

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Pacific Palisades, United States
May 2026
$87.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.

San Diego, United States
April 2026
$137.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Forte Biosciences is a biotechnology company that focuses on dermatology.

Sherman Oaks, United States
April 2026
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

Camarillo, United States
February 2024
$8.0M
Grant

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Carlsbad, United States
February 2024
$200.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPrecision Medicine

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Watertown, United States
September 2025
$200.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalWellness

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Hellerup, Denmark
October 2023
$57.4M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedicalTherapeutics

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Chicago, United States
September 2023
$81.0M
Series B

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife Science

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

London, United Kingdom
April 2023
$20.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeurosciencePharmaceuticalTherapeutics

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Cambridge, United States
January 2025
$207.5M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife Science

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Cambridge, United States
January 2025
$3.9M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.

New York, United States
December 2021
$1.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

San Francisco, United States
November 2025
$185.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

TELA Bio is a life science company that specializes in soft tissue reconstruction.

Malvern, United States
November 2025
$60.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations.

Jerusalem, Israel
May 2021
$28.5M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

BioShin is a clinical stage biopharmaceutical company.

Shanghai, China
September 2020
$60.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders.

Ness Ziona, Israel
October 2018
$405K
Seed

Founder Contacts

41,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio